By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Synta Pharmaceuticals 

45 Hartwell Avenue

Lexington  Massachusetts  02421  U.S.A.
Phone: 781-274-8200 Fax: 781-274-8228



Company News
Synta Pharmaceuticals (SNTA) Announces Presentation Of Results From An Investigator-Sponsored Phase 1 Trial Of Ganetespib In HER2+ Metastatic Breast Cancer At The 2014 San Antonio Breast Cancer Symposium 12/12/2014 7:54:39 AM
Synta Pharmaceuticals (SNTA) Reports Inducement Grants To New Chief Operating Officer And New Chief Financial Officer 12/11/2014 7:39:06 AM
Synta Pharmaceuticals (SNTA) Strengthens Management Team With Two Executive Appointments 12/5/2014 9:28:24 AM
Synta Pharmaceuticals (SNTA) Announces Presentation On Hsp90 inhibitor Drug Conjugate Platform At 26th EORTC-NCI-AACR Symposium 11/19/2014 5:08:51 PM
Synta Pharmaceuticals (SNTA) To Present At The Stifel 2014 Healthcare Conference 11/13/2014 10:38:58 AM
Synta Pharmaceuticals (SNTA) Reports Third Quarter Financial Results And Provides Corporate Update 11/6/2014 11:15:28 AM
Synta Pharmaceuticals (SNTA) Announces FDA’s Oncologic Drugs Advisory Committee To Discuss Pediatric Uses For Ganetespib 11/5/2014 10:57:00 AM
Synta Pharmaceuticals (SNTA) Announces Initiation Of I-SPY 2 TRIAL Of Ganetespib In Breast Cancer 10/29/2014 9:53:51 AM
Synta Pharmaceuticals (SNTA) To Host Conference Call And Webcast Of Third Quarter 2014 Financial Results On November 6, 2014 10/28/2014 9:31:11 AM
Synta Pharmaceuticals (SNTA) Reports Inducement Grant To New Chief Executive Officer 9/5/2014 12:13:31 PM